Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1aCondition 1bCondition 2aCondition 2b
12post-insult time to onset of diabetes mellitusBBDR/Rhwnot specified11danti-RT6.1 antibody (2 ml) (for 28 days) and Poly I:C (5 ug/g) (for 28 days)66148anti-RT6.1 antibody (2 ml) (for 28 days)Poly I:C (5 ug/g) (for 28 days)
12percentage of study population developing type 1 diabetes mellitus during a period of timeBBDR/Rhwnot specified100%anti-RT6.1 antibody (2 ml) (for 28 days) and Poly I:C (5 ug/g) (for 28 days)66147anti-RT6.1 antibody (2 ml) (for 28 days)Poly I:C (5 ug/g) (for 28 days)
75blood CD4 cell to R73 cell ratioBBDR/Rhwnot specified75%specific pathogen-free conditions67843specific pathogen-free conditions
75blood R73 cell to total mononuclear cell ratioBBDR/Rhwnot specified60%specific pathogen-free conditions67842specific pathogen-free conditions
75blood CD8 cell count to R73 cell count ratioBBDR/Rhwnot specified22%specific pathogen-free conditions67844specific pathogen-free conditions
13percentage of study population developing chronic experimental arthritis during a period of timeBBDR/Rhwfemale100%Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days)69922Freund's incomplete adjuvant (50 %) (between 1 and 7 days)type II collagen (2 mg/kg) (between 1 and 7 days)Freund's incomplete adjuvant (50 %) (between 1 and 35 days)type II collagen (100 ug) (between 1 and 35 days)
11percentage of study population developing chronic experimental arthritis during a period of timeBBDR/Rhwmale100%Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days)69921Freund's incomplete adjuvant (50 %) (between 1 and 7 days)type II collagen (2 mg/kg) (between 1 and 7 days)Freund's incomplete adjuvant (50 %) (between 1 and 35 days)type II collagen (100 ug) (between 1 and 35 days)
13calculated serum anti-rat type 2 collagen autoantibody titerBBDR/Rhwfemale31.7Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) 69926Freund's incomplete adjuvant (50 %) type II collagen (2 mg/kg)
11calculated serum anti-rat type 2 collagen autoantibody titerBBDR/Rhwmale30.6Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) 69925Freund's incomplete adjuvant (50 %) type II collagen (2 mg/kg)
75blood CD4 cell count to CD8 cell count ratioBBDR/Rhwnot specified340%specific pathogen-free conditions67846specific pathogen-free conditions